Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials
Background: Ascorbate (vitamin C) has been evaluated as a potential treatment for cancer as an independent agent and in combination with standard chemotherapies. This review assesses the evidence for safety and clinical effectiveness of intravenous (IV) ascorbate in treating various types of cancer....
Main Authors: | Gina Nauman, Javaughn Corey Gray, Rose Parkinson, Mark Levine, Channing J. Paller |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-07-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-3921/7/7/89 |
Similar Items
-
Stability of aqueous solutions of ascorbate for basic research and for intravenous administration
by: Brett A. Wagner, et al.
Published: (2023-12-01) -
The Use of Intravenous Vitamin C as a Supportive Therapy for a Patient with Glioblastoma Multiforme
by: Nicola Baillie, et al.
Published: (2018-08-01) -
Low Vitamin C Concentrations in Patients with Community-Acquired Pneumonia Resolved with Pragmatic Administration of Intravenous and Oral Vitamin C
by: Anitra C. Carr, et al.
Published: (2023-08-01) -
Efficacy of intravenous vitamin C in management of moderate and severe COVID-19: A double blind randomized placebo controlled trial
by: Vijay Kumar, et al.
Published: (2022-01-01) -
The Role of Vitamin C in Cancer Prevention and Therapy: A Literature Review
by: Marcelo Villagran, et al.
Published: (2021-11-01)